Financials
Income statement
| Fiscal date | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|
| Total reported revenue | 40.6B | 39.1B | 36.5B | 40.1B |
| Cost of revenue | 7.4B | 7.3B | 6.6B | 7.7B |
| Gross profit | 33.2B | 31.8B | 29.8B | 32.4B |
| Operating expense | ||||
| Research & development | 11.2B | 10.5B | 10.0B | 10.5B |
| Selling general and admin | 4.7B | 6.4B | 6.0B | 5.5B |
| Other operating expenses | — | — | — | — |
| Operating income | 17.4B | 14.8B | 13.8B | 16.4B |
| Non operating interest income | ||||
| Income | 661M | 540M | 585M | 588M |
| Expense | 208M | 128M | 127M | 136M |
| Other income expense | 11M | -168M | -148M | -61M |
| Pretax income | 17.8B | 15.1B | 14.2B | 16.8B |
| Tax provision | 2.1B | 1.6B | 1.8B | 2.8B |
| Net income | 15.7B | 13.5B | 12.4B | 14.0B |
| Basic EPS | 6.2 | 5.3 | 4.9 | 5.5 |
| Diluted EPS | 6.0 | 5.2 | 4.7 | 5.3 |
| Basic average shares | 2.5B | 2.5B | 2.5B | 2.6B |
| Diluted average shares | 2.6B | 2.6B | 2.6B | 2.6B |
| EBITDA | 22.0B | 19.0B | 17.8B | 20.2B |
| Net income from continuing op. | 15.7B | 13.5B | 12.4B | 14.0B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |